Current Management of Gallbladder Carcinoma
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Gallbladder cancer (GBC) represents the most common and aggressive type among the biliary tree cancers (BTCs). Complete surgical resection offers the only chance for cure; however, only 10% of patients with GBC present with early-stage disease and are considered surgical candidates. Among those patients who do undergo “curative” resection, recurrence rates are high. There are no established adjuvant treatments in this setting. Patients with unresectable or metastatic GBC have a poor prognosis. There has been a paucity of randomized phase III data in this field. A recent report demonstrated longer overall survival with gemcitabine in combination with cisplatin than with gemcitabine alone in patients with advanced or metastatic BTCs. Molecularly targeted agents are under development. In this review, we attempt to discuss the current status and key issues involved in the management of GBC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
Burris, H. A., Moore, M. J., Andersen, J., Green, M. R., Rothenberg, M. L., Modiano, M. R., Cripps, M. C., Portenoy, R. K., Storniolo, A. M., Tarassoff, P., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2403 · Cited by 5,894
Oettle, H., Post, S., Neuhaus, P., Gellert, K., Langrehr, J., Ridwelski, K., Schramm, H., Fahlke, J., Zuelke, C., Burkart, C., et al. (2007) · JAMA · doi:10.1001/jama.297.3.267 · Cited by 2,419
Benson, A. B., Abrams, T. A., Ben-Josef, E., Bloomston, P. M., Botha, J. F., Clary, B. M., Covey, A., Curley, S. A., D'Angelica, M. I., Davila, R., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0027 · Cited by 2,268
Self-citationJarnagin, W. R., Gönen, M., Fong, Y., DeMatteo, R. P., Ben‐Porat, L., Little, S., Corvera, C. U., Weber, S., & Blumgart, L. H. (2002) · PubMed · doi:10.1097/01.sla.0000029003.66466.b3 · Cited by 1,474
LLUSIA, J. B. (1983) · PubMed · Cited by 1,289
Jarnagin, W. R., Gonen, M., Fong, Y., DeMatteo, R. P., Ben-Porat, L., Little, S., Corvera, C., Weber, S., & Blumgart, L. H. (2002) · Annals of Surgery · doi:10.1097/00000658-200210000-00001 · Cited by 1,258
Misra, S., Chaturvedi, A., Misra, N. C., & Sharma, I. D. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01021-0 · Cited by 812
Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer
Glimelius, B., Hoffman, K., Sjödén, P.-O., Jacobsson, G., Sellström, H., Enander, L.-K., Linné, T., & Svensson, C. (1996) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a010676 · Cited by 797
Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials
Eckel, F., & Schmid, R. M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603648 · Cited by 464
Jarnagin, W. R., Ruo, L., Little, S. A., Klimstra, D., D'Angelica, M., DeMatteo, R. P., Wagman, R., Blumgart, L. H., & Fong, Y. (2003) · Cancer · doi:10.1002/cncr.11699 · Cited by 454
Gallbladder cancer: lessons from a rare tumour
Wistuba, I. I., & Gazdar, A. F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1429 · Cited by 454
André, T., Tournigand, C., Rosmorduc, O., Provent, S., Maindrault-Goebel, F., Avenin, D., Selle, F., Paye, F., Hannoun, L., Houry, S., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh351 · Cited by 380
Phase II Study of Erlotinib in Patients With Advanced Biliary Cancer
Philip, P. A., Mahoney, M. R., Allmer, C., Thomas, J., Pitot, H. C., Kim, G., Donehower, R. C., Fitch, T., Picus, J., & Erlichman, C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.3579 · Cited by 318
Combining Gemcitabine and Capecitabine in Patients With Advanced Biliary Cancer: A Phase II Trial
Knox, J. J., Hedley, D. W., Oza, A. M., Feld, R., Siu, L. L., Chen, E. X., Nematollahi, M., Pond, G. R., Zhang, J., & Moore, M. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.51.008 · Cited by 305
Zhu, A. X., Meyerhardt, J. A., Blaszkowsky, L. S., Kambadakone, A. R., Muzikansky, A., Zheng, H., Clark, J. W., Abrams, T. A., Chan, J. A., Enzinger, P. C., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70333-x · Cited by 303
Self-citationSHIRAI, Y., YOSHIDA, K., TSUKADA, K., & MUTO, T. (1992) · Annals of Surgery · doi:10.1097/00000658-199204000-00004 · Cited by 291
A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer
Ramanathan, R. K., Belani, C. P., Singh, D. A., Tanaka, M., Lenz, H.-J., Yen, Y., Kindler, H. L., Iqbal, S., Longmate, J., Mack, P. C., et al. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-0927-7 · Cited by 284
Nakazawa, K., Dobashi, Y., Suzuki, S., Fujii, H., Takeda, Y., & Ooi, A. (2005) · The Journal of Pathology · doi:10.1002/path.1779 · Cited by 234
Donohue, J. H. (1990) · Archives of Surgery · doi:10.1001/archsurg.1990.01410140115019 · Cited by 232
Systemic Therapy for Biliary Tract Cancers
Hezel, A. F., & Zhu, A. X. (2008) · The Oncologist · doi:10.1634/theoncologist.2007-0252 · Cited by 208
Self-citationRadical Surgery for Gallbladder Carcinoma Long-term Results
SHIRAI, Y., YOSHIDA, K., TSUKADA, K., MUTO, T., & WATANABE, H. (1992) · Annals of Surgery · doi:10.1097/00000658-199211000-00007 · Cited by 205
Kubicka, S., Rudolph, K. L., Tietze, M. K., Lorenz, M., & Manns, M. P. (2001) · PubMed · Cited by 170
Somatic Mutations of Epidermal Growth Factor Receptor in Bile Duct and Gallbladder Carcinoma
Leone, F., Cavalloni, G., Pignochino, Y., Sarotto, I., Ferraris, R., Piacibello, W., Venesio, T., Capussotti, L., Risio, M., & Aglietta, M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1692 · Cited by 170
Thongprasert, S., Napapan, S., Charoentum, C., & Moonprakan, S. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi046 · Cited by 141
Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer
Harder, J., Riecken, B., Kummer, O., Lohrmann, C., Otto, F., Usadel, H., Geißler, M., OPITZ, O. G., & Henß, H. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603334 · Cited by 133
Wakai, T., Shirai, Y., & Hatakeyama, K. (2002) · World Journal of Surgery · doi:10.1007/s00268-002-6274-z · Cited by 128
Alberts, S. R., Alkhatib, H., Mahoney, M. R., Burgart, L. J., Cera, P. J., Flynn, P. J., Finch, T. R., Levitt, R., Windschitl, H. E., Knost, J. A., et al. (2004) · Cancer · doi:10.1002/cncr.20753 · Cited by 123
Gwak, G., Yoon, J., Shin, C. M., Ahn, Y. J., Chung, J., Kim, Y. A., Kim, T., & Lee, H. S. (2005) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-005-0016-1 · Cited by 108
Surgical strategies in patients with gallbladder cancer: Nihilism to optimism
Sikora, S. S., & Singh, R. K. (2006) · Journal of Surgical Oncology · doi:10.1002/jso.20535 · Cited by 105
Kiran, R. P., Pokala, N., & Dudrick, S. J. (2006) · Annals of Surgical Oncology · doi:10.1245/s10434-006-9224-4 · Cited by 104
Paule, B., Herelle, M.-O., Rage, E., Ducreux, M. P., Adam, R. A., Guettier, C., & Bralet, M. (2007) · Oncology · doi:10.1159/000111117 · Cited by 102
Rare PIK3CA hotspot mutations in carcinomas of the biliary tract
Riener, M., Bawohl, M., Clavien, P., & Jochum, W. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20540 · Cited by 92
Appraisal of surgical treatment for pT2 gallbladder carcinomas
Suzuki, S., Yokoi, Y., Kurachi, K., Inaba, K., Ota, S., Azuma, M., Konno, H., Baba, S., & Nakamura, S. (2004) · World Journal of Surgery · doi:10.1007/s00268-003-7080-y · Cited by 81
Saetta, A. A., Papanastasiou, P., Michalopoulos, N., Gigelou, F., Korkolopoulou, P. A., Bei, T., & Patsouris, E. (2004) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-004-1046-9 · Cited by 71
Alterations of p16 and Prognosis in Biliary Tract Cancers from a Population-Based Study in China
Ueki, T., Hsing, A. W., Gao, Y.-T., Wang, B.-S., Shen, M.-C., Cheng, J., Deng, J., Fraumeni, J. F., & Rashid, A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1137-3 · Cited by 62
Itoh, H., Nishijima, K., Kurosaka, Y., et al. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-3040-8 · Cited by 57
Telomere length variation in biliary tract metaplasia, dysplasia, and carcinoma
Hansel, D. E., Meeker, A. K., Hicks, J. L., Marzo, A. M. D., Lillemoe, K. D., Schulick, R. D., Hruban, R. H., Maitra, A., & Argani, P. (2006) · Modern Pathology · doi:10.1038/modpathol.3800591 · Cited by 57
Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer
Hong, Y. S., Lee, J., Lee, S. C., Hwang, I. G., Choi, S., Heo, J., Park, J. O., Park, Y. S., Lim, H. Y., & Kang, W. K. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0380-9 · Cited by 56
Irinotecan With 5-FU/FA in Advanced Biliary Tract Adenocarcinomas: A Multicenter Phase II Trial
Feisthammel, J., Schoppmeyer, K., Mössner, J., Schulze, M., Caca, K., & Wiedmann, M. W. (2007) · American Journal of Clinical Oncology · doi:10.1097/01.coc.0000258124.72884.7a · Cited by 45
Valle, J. W., Wasan, H. S., Palmer, D., Cunningham, D., Anthoney, A., Maraveyas, A., Hughes, S. K., Roughton, M., & Bridgewater, J. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.15_suppl.4503 · Cited by 45
Alvarez, H., Corvalán, A. H., Roa, J. C., Argani, P., Murillo, F., Edwards, J. B., Beaty, R. M., Feldmann, G., Hong, S., Mullendore, M. E., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1991 · Cited by 39
Gallbladder Cancer, a Different Disease that Needs Individual Trials
Gallardo, J., Rubio, B., Villanueva, L., & Barajas, O. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.7524 · Cited by 24
Cited by
Ma, M.-Z., Chu, B.-F., Zhang, Y., Weng, M.-Z., Qin, Y.-Y., Gong, W., & Quan, Z.-W. (2015) · Cell Death & Disease · doi:10.1038/cddis.2014.541 · Cited by 328
Gallbladder Cancer in the 21st Century
Kanthan, R., Senger, J.-L., Ahmed, S., & Kanthan, S. C. (2015) · Journal of Oncology · doi:10.1155/2015/967472 · Cited by 295
Metadata
- Authors
- Zhu, A. X., Hong, T. S., Hezel, A. F., & Kooby, D. A.
- Venue
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-02-01
- Volume
- 15
- Issue
- 2
- Pages
- 168-181
- ISSN
- 1083-7159 (ISSN-L)
- 1549-490X
- OpenAlex
- W2108015399
- Cited by
- 343
- References
- 44
- FWCI
- 13.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.